Positive News Coverage Somewhat Unlikely to Affect Jaguar Animal Health (JAGX) Stock Price
Media stories about Jaguar Animal Health (NASDAQ:JAGX) have been trending positive recently, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Jaguar Animal Health earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned news headlines about the biotechnology company an impact score of 46.258321903126 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the headlines that may have effected Accern Sentiment’s analysis:
- Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Friday, December 15, 2017 – Business Wire (press release) (businesswire.com)
- Keep Your Pants On Campaign From Napo Pharmaceuticals Chosen as Best HIV-Related Awareness Campaign of 2017 by Healthline (finance.yahoo.com)
- What You Must Know About Jaguar Health Inc’s (JAGX) Financial Strength (finance.yahoo.com)
- Jaguar Animal Health (JAGX) Enters Share Purchase Agreement for 2M Shares and Common Stock Purchase … – StreetInsider.com (streetinsider.com)
Jaguar Animal Health (NASDAQ JAGX) opened at $0.14 on Wednesday. Jaguar Animal Health has a one year low of $0.10 and a one year high of $1.53. The company has a quick ratio of 0.15, a current ratio of 0.26 and a debt-to-equity ratio of 0.35.
WARNING: “Positive News Coverage Somewhat Unlikely to Affect Jaguar Animal Health (JAGX) Stock Price” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://theolympiareport.com/2017/12/06/positive-news-coverage-somewhat-unlikely-to-affect-jaguar-animal-health-jagx-stock-price.html.
About Jaguar Animal Health
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Animal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.